{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:06:12Z","timestamp":1774566372004,"version":"3.50.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interleukin (IL)-4 and (IL)-13 induce immunoglobulin (Ig)E synthesis via activation of the transcription factor signal transducer and activator of transcription (Stat)6. The present study describes the identification and characterization of antisense oligonucleotides to Stat6 as an approach to interrupt IL-4 and IL-13 signaling and thereby to attenuate germline C\u03b5 transcription, a prerequisite to IgE synthesis. A limited gene-walk was performed with chemically modified oligonucleotides to identify sequences capable of downregulating both human and murine Stat6. A chimeric oligonucleotide (9b, base sequence GTGAGGTCCTGTTCAGTGGG) demonstrated high levels of antisense activity in both species. Further characterization of 9b showed a dose-dependent Stat6 messenger RNA (mRNA) and protein downregulation (concentration that produces 50% inhibition of effect = 168 and 215 nM, respectively) through a ribonuclease H-dependent antisense mechanism with no effect on closely related members of the Stat family. Further, pretreatment of DND39 cells (human Burkitt lymphoma cell line) with oligonucleotide 9b before IL-4 stimulation successfully downregulated germline C\u03b5 transcription. Because Stat6 represents an attractive but technically challenging drug discovery target, antisense oligonucleotides may provide an alternative approach to low molecular-weight compounds for inhibiting IL-4 and IL-13 signaling.<\/jats:p>","DOI":"10.1165\/ajrcmb.21.6.3709","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T22:05:27Z","timestamp":1365026727000},"page":"728-737","source":"Crossref","is-referenced-by-count":14,"title":["Homologous Human and Murine Antisense Oligonucleotides Targeting\n                    <i>Stat6<\/i>\n                    : Functional Effects on Germline C \u03b5 Transcript"],"prefix":"10.1093","volume":"21","author":[{"given":"Sandra","family":"Hill","sequence":"first","affiliation":[{"name":"Molecular and Cell Biology Unit, Novartis Horsham Research Centre, West Sussex, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Herlaar","sequence":"additional","affiliation":[{"name":"Molecular and Cell Biology Unit, Novartis Horsham Research Centre, West Sussex, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Le Cardinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"van Heeke","sequence":"additional","affiliation":[{"name":"Molecular and Cell Biology Unit, Novartis Horsham Research Centre, West Sussex, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Nicklin","sequence":"additional","affiliation":[{"name":"Molecular and Cell Biology Unit, Novartis Horsham Research Centre, West Sussex, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"2026030700095365200_B1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/380627a0","article-title":"Essential role of Stat6 in IL-4 signaling.","volume":"380","author":"Takeda","year":"1996","journal-title":"Nature"},{"key":"2026030700095365200_B2","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.4049\/jimmunol.157.8.3220","article-title":"Impaired IL-13-mediated functions of macrophages in Stat6-deficient mice.","volume":"157","author":"Takeda","year":"1996","journal-title":"J. Immunol."},{"key":"2026030700095365200_B3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/380630a0","article-title":"Lack of IL-4- induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.","volume":"380","author":"Shimoda","year":"1996","journal-title":"Nature"},{"key":"2026030700095365200_B4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.161.1.302","article-title":"Stat6 is required for IL-4-induced germline Ig gene transcription and switch recombination.","volume":"161","author":"Linehan","year":"1998","journal-title":"J. Immunol."},{"key":"2026030700095365200_B5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15.","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"key":"2026030700095365200_B6","doi-asserted-by":"crossref","first-page":"13869","DOI":"10.1074\/jbc.270.23.13869","article-title":"The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin\u201313 receptor.","volume":"270","author":"Zurawski","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2026030700095365200_B7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/bst0250451","article-title":"Interleukin 4 and interleukin 13: same response, different receptors.","volume":"25","author":"Callard","year":"1997","journal-title":"Biochem. Soc. Trans."},{"key":"2026030700095365200_B8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.172.2.463","article-title":"Structure and expression of germline epsilon transcripts in human B cells induced by interleukin-4 to switch to IgE production.","volume":"172","author":"Gauchat","year":"1990","journal-title":"J. Exp. Med."},{"key":"2026030700095365200_B9","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026030700095365200_B10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisition of lymphokine-producing phenotype by CD4+ T cells.","volume":"12","author":"Seder","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"2026030700095365200_B11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0167-5699(92)90083-J","article-title":"Induction of Th1 and Th2 responses: a key role for the \u201cnatural\u201d immune response?","volume":"13","author":"Romagnani","year":"1992","journal-title":"Immunol. Today"},{"key":"2026030700095365200_B12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.iy.12.040194.001303","article-title":"Lymphokine production by human T cells in disease states.","volume":"12","author":"Romagnani","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"2026030700095365200_B13","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors.","volume":"145","author":"Swain","year":"1990","journal-title":"J. Immunol."},{"key":"2026030700095365200_B14","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma.","volume":"282","author":"Gr\u00fcnig","year":"1998","journal-title":"Science"},{"key":"2026030700095365200_B15","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin\u201313: central mediator of allergic asthma.","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"2026030700095365200_B16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/362245a0","article-title":"Disruption of the murine IL-4 gene blocks Th2 cytokine responses.","volume":"362","author":"Kopf","year":"1993","journal-title":"Nature"},{"key":"2026030700095365200_B17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1074-7613(00)80625-1","article-title":"Impaired development of Th2 cells in IL-13-deficient mice.","volume":"9","author":"McKenzie","year":"1998","journal-title":"Immunity"},{"key":"2026030700095365200_B18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.1948049","article-title":"Generation and analysis of interleukin-4 deficient mice.","volume":"254","author":"K\u00fchn","year":"1991","journal-title":"Science"},{"key":"2026030700095365200_B19","doi-asserted-by":"crossref","first-page":"33893","DOI":"10.1074\/jbc.273.51.33893","article-title":"Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.","volume":"273","author":"Haque","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2026030700095365200_B20","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.8266078","article-title":"Interleukin-2 receptor \u03b3 chain: a functional component of the interleukin-4 receptor.","volume":"262","author":"Russell","year":"1993","journal-title":"Science"},{"key":"2026030700095365200_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(00)80505-1","article-title":"Jaks, Stats, cytokine signal transduction, and immunoregulation: are we there yet?","volume":"7","author":"O'Shea","year":"1997","journal-title":"Immunity"},{"key":"2026030700095365200_B22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s001090050117","article-title":"Stat6: its role in interleukin 4-mediated biological functions.","volume":"75","author":"Takeda","year":"1997","journal-title":"J. Mol. Med."},{"key":"2026030700095365200_B23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-7613(00)80439-2","article-title":"Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells.","volume":"4","author":"Kaplan","year":"1996","journal-title":"Immunity"},{"key":"2026030700095365200_B24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/eji.1830270823","article-title":"Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene.","volume":"27","author":"Curiel","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"2026030700095365200_B25","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.160.7.3299","article-title":"In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and \u03b22-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.","volume":"160","author":"Morris","year":"1998","journal-title":"J. Immunol."},{"key":"2026030700095365200_B26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.187.6.939","article-title":"Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyper-responsiveness and mucus production.","volume":"187","author":"Kuperman","year":"1998","journal-title":"J. Exp. Med."},{"key":"2026030700095365200_B27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026030700095365200_B28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.75.1.285","article-title":"Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.","volume":"75","author":"Stephenson","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026030700095365200_B29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/phrs.1997.0227","article-title":"Antisense oligonucleotides as therapeutic agents.","volume":"36","author":"Alama","year":"1997","journal-title":"Pharmacol. Res."},{"key":"2026030700095365200_B30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1042\/bst0240623","article-title":"Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents.","volume":"24","author":"Dean","year":"1996","journal-title":"Biochem. Soc. Trans."},{"key":"2026030700095365200_B31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)36471-7","article-title":"An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J.","volume":"280","author":"Bennett","year":"1997","journal-title":"Pharmacol. Exp. Ther."},{"key":"2026030700095365200_B32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(95)02177-9","article-title":"Effect of different chemically modified oligodeoxynucleotides on immune stimulation.","volume":"51","author":"Zhao","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"2026030700095365200_B33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/oli.1.1996.6.133","article-title":"Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs.","volume":"6","author":"Krieg","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"2026030700095365200_B34"},{"key":"2026030700095365200_B35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0167-7799(96)20006-X","article-title":"Phosphorothioate antisense oligodeoxynucleotides: questions of specificity.","volume":"14","author":"Stein","year":"1996","journal-title":"Trends Biotechnol."},{"key":"2026030700095365200_B36"},{"key":"2026030700095365200_B37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2533\/chimia.1996.168","article-title":"Second generation of antisense oligonucleotides: from nuclease resistance to biological efficacy in animals.","volume":"50","author":"Altmann","year":"1996","journal-title":"Chimia"},{"key":"2026030700095365200_B38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/intimm\/4.7.747","article-title":"The effect of cytokines and mitogens on the induction of C\u03b5 germline transcripts in a human Burkitt lymphoma cell line.","volume":"4","author":"Ichiki","year":"1992","journal-title":"Int. Immunol."},{"key":"2026030700095365200_B39","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1073\/pnas.88.17.7528","article-title":"Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells.","volume":"88","author":"Shapira","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026030700095365200_B40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.175.1.289","article-title":"Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen.","volume":"175","author":"Shapira","year":"1992","journal-title":"J. Exp. Med."},{"key":"2026030700095365200_B41","first-page":"12135","article-title":"CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.","volume":"91","author":"Castigli","year":"1994","journal-title":"Immunology"},{"key":"2026030700095365200_B42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/4.3.397","article-title":"Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumour necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production.","volume":"4","author":"Gauchat","year":"1992","journal-title":"Int. Immunol."},{"key":"2026030700095365200_B43","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/S0960-894X(98)00591-5","article-title":"Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects.","volume":"8","author":"Zhou","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026030700095365200_B44","first-page":"107","article-title":"First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinase.","volume":"209","author":"Monia","year":"1997","journal-title":"Ciba Found. Symp."},{"key":"2026030700095365200_B45","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1074\/jbc.274.3.1715","article-title":"Characterisation of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-\u03b1 expression.","volume":"274","author":"McKay","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2026030700095365200_B46","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","article-title":"2\u2032-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells.","volume":"272","author":"Baker","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2026030700095365200_B47","doi-asserted-by":"crossref","first-page":"15481","DOI":"10.1073\/pnas.93.26.15481","article-title":"Sequence-specific antitumour activity of phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.","volume":"93","author":"Monia","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2026030700095365200_B48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4049\/jimmunol.159.3.1255","article-title":"Identification of a Stat6 domain required for IL-4-induced activation of transcription.","volume":"159","author":"Lu","year":"1997","journal-title":"J. Immunol."},{"key":"2026030700095365200_B49","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.150.12.5408","article-title":"Regulation of the expression of human C\u03b5 germline transcript. Identification of a novel IL-4 responsive element","volume":"150","author":"Ichiki","year":"1993","journal-title":"J. Immunol."},{"key":"2026030700095365200_B50"},{"key":"2026030700095365200_B51"},{"key":"2026030700095365200_B52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.280.10.871-JMN0909-6-1","article-title":"First \u201cantisense\u201d drug will treat CMV retinitis.","volume":"280","author":"Marwick","year":"1998","journal-title":"JAMA"},{"key":"2026030700095365200_B53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1470-8744.1997.tb00448.x","article-title":"Antisense oligonucleotides: a new therapeutic approach.","volume":"26","author":"Temsamani","year":"1997","journal-title":"Biotechnol. Appl. Biochem."},{"key":"2026030700095365200_B54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0167-7799(96)10053-6","article-title":"Antisense oligonucleotides: towards clinical trials.","volume":"14","author":"Agrawal","year":"1996","journal-title":"Trends Biotechnol."}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/21\/6\/728\/67191986\/ajrcmb_21_6_728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/21\/6\/728\/67191986\/ajrcmb_21_6_728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:20:48Z","timestamp":1772860848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/21\/6\/728\/8502837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1165\/ajrcmb.21.6.3709","relation":{},"ISSN":["1535-4989","1044-1549"],"issn-type":[{"value":"1535-4989","type":"electronic"},{"value":"1044-1549","type":"print"}],"subject":[],"published-other":{"date-parts":[[1999,12]]},"published":{"date-parts":[[1999,12,1]]}}}